Frontlight ResearchEarly access
CompletedNo phase
Home Rehabilitation After Acute Pulmonary Embolism
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 19 Dec 2022
- Ended
- 24 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Daily Activity Text
- Control Text
- Record updated
- 18 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- English speaking (>18 years old). Daily messages will be sent in English
- Acute PE with right ventricular enlargement or dysfunction defined by echocardiogram report, CT Angiogram report, or elevated cardiac biomarker (NT-pro BNP or troponin)
- Baseline testing started within 7 days of hospital discharge
Who cannot take part
- Participation in a structured exercise routine at least three days per week in the prior four weeks
- Cardiac Effort >2.5 beats/m during 6MWT. This is for safety
- Cardiac Effort <1.2 beats/m during 6MWT. They are unlikely to benefit
- Suspicion for Chronic Thromboembolic Pulmonary Hypertension
- Advanced neurologic disease
- Pregnancy
- Resting tachycardia >120 beats/m during screening or at hospital discharge
- Systolic blood pressure >180 mmHg during screening or at hospital discharge
- Inability to walk
- Estimated prognosis <12 months at the time of discharge due to underlying co-morbidities
- Lack of access to email or text messaging
- Inability to follow daily instructions
- Principal Investigator discretion
Where in United States
- University of Rochester Medical CenterRochester, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.
The 2 groups in the trial
- Participants who receive daily activity messageTreatment being tested
The intervention group will receive instructions for a daily activity sent through SMS text message or email.
Treatment: Daily Activity Text
- Participants who receive control messagePlacebo, for comparison
The control group will receive daily messages to help with blinding sent through text message or email. The messages will not include activity tasks and will include phrases such as "I hope you have a good day".
Treatment: Control Text
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 18 September 2026